Do sex differences in paediatric type 1 diabetes care exist? A systematic review
de Vries SAG, Verheugt CL, Mul D, et al.
Diabetologia. Pub. online 26 Jan 2023.
Leggi
Breaking news
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies
Hinton W, Ansari AS, Whyte MB, et al.
Diabetes Obes Metab. 2023;25(2):501-515.
Leggi
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset
Carrera P, Marzinotto I, Bonfanti R, et al.
Diabetologia. Pub. online 24 Jan 2023.
Leggi
Comparison of cardiovascular mortality between MAFLD and NAFLD: a cohort study
Yoo TK, Lee MY, Kim SH, et al.
NMCD. Pub. Online 24 Jan 2023.
Leggi
Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
Fawzy AM, Rivera-Caravaca JM, Underhill P, et al.
Diabetes Obes Metab. 2023;25(2):602-610.
Leggi
Albuminuria and heart failure: JACC State-of-the-Art Review
Khan MS, Shahid I, Anker SD, et al.
J Am Coll Cardiol. 2023;81(3):270-82.
Leggi
Identifying diabetogenic drugs using real world healthcare databases: a Danish and Australian symmetry analysis
Lund LC, Hjorslev Jensen P, Pottegård A, et al.
Diabetes Obes Metab. Pub. Online 22 Jan 2023.
Leggi
Diabetic foot problems: prevention and management
NICE. Update Pub. 18 Jan 2023.
Leggi
The global burden of disease attributable to metabolic risks in 204 countries and territories from 1990 to 2019
Hu W, Zhai C, Sun H, et al.
Diabetes Res Clin Pract. 2023;110260.
Leggi
Rollout of closed-loop technology to pregnant women with type 1 diabetes: healthcare professionals’ views about potential challenges and solutions
Rankin D, Hart R, Kimbell B, et al.
Pub. online 20 Jan 2023.
Leggi